Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (10): 58-63.doi: 10.6040/j.issn.1671-7554.0.2018.1019

Previous Articles    

A study of serum PIVKA-II in patients with liver metastasis of colorectal cancer

ZHU Yu, WANG Hongjie, HAN Binbin, FENG Shana, ZHANG Chun, LI Xuexiang, HAN Xiaohong, CUI Wei   

  1. Department of Clinical Laboratory, National Cancer Center;
    National Clinical Research Center for Cancer;
    Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2018-09-03 Published:2022-09-27

Abstract: Objective To evaluate the diagnostic value of serum prothrombin induced by vitamin K absence or antagonist-II(PIVKA-II)in patients with liver metastasis of colorectal cancer(CRC). Methods A total of 120 CRC patients(including 80 without organ metastasis and 40 with liver metastasis), 80 patients with early-stage hepatocellular carcinoma(HCC)and 80 healthy controls were involved in the study. The levels of serum PIVKA-II and carcinoembryonic antigen(CEA)were determined to evaluate the optimal cut-off values. The diagnostic sensitivity and specificity of PIVKA-II and CEA for the liver metastasis of CRC were analyzed. Results The median concentrations of serum PIVKA-II in healthy controls, CRC patients without organ metastasis, CRC patients with liver metastasis and early-stage HCC patients were 18(15-20.8)mAU/mL, 20(17-24)mAU/mL, 32(22.3-41.8)mAU/mL and 345(31.8-3 787)mAU/mL, respectively. The median PIVKA-II level was significantly greater in CRC patients with liver metastasis 山 东 大 学 学 报 (医 学 版)56卷10期 -朱宇,等.人异常凝血酶原(PIVKA-II)在监测结直肠癌肝转移中的应用 \=-than that in healthy controls (P<0.001)and CRC patients without organ metastasis(P<0.001), but significantly lower than that in early-stage HCC patients(P<0.001). There was no significant difference between PIVKA-II and CEA in the area under the receiver operating characteristic curve(AUC)[0.818(95%CI: 0.736-0.901)vs 0.799(95%CI: 0.710-0.888), Z=0.332, P=0.74]. The optimal cut-off value of PIVKA-II for the detection of CRC liver metastasis was 28.5 mAU/mL, with sensitivity of 60% and specificity of 90%. A combination of PIVKA-II and CEA increased the sensitivity(85%)in detecting CRC liver metastasis. Conclusion PIVKA-II could serve as a marker for CRC liver metastasis screening.

Key words: Prothrombin induced by vitamin k absence or antagonist-II, Carcinoembryonic antigen, Colorectal cancer, Liver metastasis, Diagnosis

CLC Number: 

  • R735.3
[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer Statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2] 中华医学会外科学分会胃肠外科学组, 中华医学会外科学分会结直肠外科学组,中国抗癌协会大肠癌专业委员会, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2018版)[J]. 中华消化外科杂志, 2018, 17(6): 527-539. Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association, Section of Colorectal Surgery, Branch of Surgery, Chinese Medical Association, Chinese Society of Colon Cancer, China Anti-cancer Association, et al. Guideline for the diagnosis and comprehensive treatment of colorectal cancer liver metastasis(2018 edition)[J]. Chinese Journal of Digestive Surgery, 2018, 17(6): 527-539.
[3] 刘鸿章, 段文都, 周超熙, 等. 血清癌胚抗原、甲胎蛋白和低聚糖肿瘤相关糖类抗原的检测应用于结直肠癌肝转移的诊断[J]. 中日友好医院学报, 2009, 23(5): 295-297.
[4] Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy(abnormal)prothrombin as a serum marker of primary hepatocellular carcinoma[J]. N Engl J Med, 1984, 310(22): 1427-1431.
[5] 朱宇, 王海, 王宏洁, 等. 血清PIVKA-II在肝癌诊断中的应用[J]. 临床和实验医学杂志, 2014, 13(7): 513-516. ZHU Yu, WANG Hai, WANG Hongjie, et al. Study on the significance of serum PIVKA-II in diagnosis of hepatoceilular carcinoma[J]. Journal of Clinical and Experimental Medicine, 2014, 13(7): 513-516.
[6] Lok AS, Sterling RK, Everhart JE, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma[J]. Gastroenterology, 2010, 138(2): 493-502.
[7] 中国抗癌协会肝癌专业委员会. 原发性肝癌的临床诊断与分期标准[J]. 中华肝脏病杂志, 2001, 6: 324.
[8] Siriwardena AK, Mason JM, Mullamitha S, et al. Management of colorectal cancer presenting with synchronous liver metastases[J]. Nat Rev Clin Oncol, 2014, 11(8): 446-459.
[9] Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors[J]. Clin Epidemiol, 2012, 4(1): 283-301.
[10] Qin X, Tang G, Gao R, et al. A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China[J]. Int J Lab Hematol, 2017, 39(4): 392-401.
[11] Venook AP, Niedzwiecki D, Innocenti F, et al. Impact of primary(1°)tumor location on overall survival(OS)and progression-free survival(PFS)in patients(pts)with metastatic colorectal cancer(mCRC): analysis of CALGB/SWOG 80405(Alliance)[J]. J Clin Oncol, 2016, 34(Suppl): 3504.
[12] Schrag D, Weng S, Brooks G, et al. The relationship between primary tumor sidedness and prognosis in colorectal cancer[J]. J Clin Oncol, 2016, 34(Suppl): 3505.
[13] Marques MC, Ribeiro HSC, Costa WL, et al. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases(CLM)[J]. J Surg Oncol, 2018, 117(5): 858-863.
[14] Park IJ, Choi GS, Lim KH, et al. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level[J]. Ann Surg Oncol, 2009, 16(11): 3087-3093.
[15] Pakdel A, Malekzadeh M, Naghibalhossaini F. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients[J]. Cancer Biomarkers, 2016, 16(2): 245-252.
[16] Gaitanidis A, Alevizakos M, Tsaroucha A. Predictive nomograms for synchronous distant metastasis in rectal cancer[J]. J Gastrointest Surg, 2018, 22(7): 1268-1276.
[17] 邓玉雪, 官玲玲. 比较几种血清肿瘤标志物在结直肠癌及其肝转移的诊断价值[J]. 中国实用医药, 2017, 12(13): 79-80.
[18] Yang WL, Luo YS, Hu SC, et al. Value of combined detection of serum carcino-embryonic antigen, carbohydrate antigen 19-9 and cyclooxygenase-2 in the diagnosis of colorectal cancer[J]. Oncol Lett, 2018, 16(2): 1551-1556.
[19] 石援援, 薄晓通, 董翠梅, 等. 结直肠癌患者血清CEA、CA199的表达变化与肝转移的多因素相关性分析[J]. 肿瘤药学, 2018, 8(3): 387-391. SHI Yuanyuan, BO Xiaotong, DONG Cuimei, et al. The expression of serum CEA and CA199 in colorectal Cancer patients and analysis on its relationship with liver metastasis[J]. Anti-Tumor Pharmacy, 2018, 8(3): 387-391.
[20] Xing H, Yan CL, Cheng LM, et al. Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma[J]. Tumor Biol, 2016, 37(12): 15447-15456.
[21] Cui SX, Yu XF, Qu XJ, et al. Roles and signaling pathways of des-γ-carboxyprothrombin in the progression of hepatocellular carcinoma[J]. Cancer invest, 2016, 34(9): 459-464.
[22] Inagaki Y, Tang W, Makuuchi M, et al. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-gamma-carboxyprothrombin[J]. Liver Int, 2011, 31(1): 22-35.
[23] Lee JH, Lee SW. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches[J]. Gastroenterol Res Pract, 2017, 2017: 7521987. doi:10.1155/2017/7521987.
[24] Sharma B, Srinivasan R, Chawla YK, et al. Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population[J]. Hepatol Int, 2010, 4(3): 569-576.
[25] Ertle JM, Heider D, Wichert M, et al. A combination of alpha-fetoprotein and des-gamma-carboxy prothrombin is superior in detection of hepatocellular carcinoma[J]. Digestion, 2013, 87(2): 121-131.
[1] LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57.
[2] LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61.
[3] XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64.
[4] WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94.
[5] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[6] JIANG Ziqing, ZENG Yanping, JI Xiaodong, ZUO Junling. A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 91-97.
[7] ZHANG Jingliang, LIU Xinyu, YUAN Suomao, WANG Lianlei. Causes of misdiagnosis and mistreatment of lumbar degenerative diseases complicated with hip joint diseases(hip-spine syndrome) [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 67-73.
[8] SONG Min, ZHOU Yuxia, GAO Lu, LIU Na, WANG Ju, GU Jin, ZHANG Yanping. Prenatal diagnosis for a fetus of mosaic trisomy 6q [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 109-113.
[9] ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95.
[10] SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42.
[11] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[12] CHEN Gang, ZHANG Yanping, YE Leping, FU Chong, ZHOU Chunyan, ZHANG Shidong. Diagnostic value of contrast-enhanced endoscopic ultrasonography combined with endoscopic ultrasound-guided fine needle aspiration for pancreatic masses [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 68-73.
[13] SUN Fuyun, WANG Weipeng, ZHANG Huihui, GENG Yan, AN Xiaoxia, LI Shuangshuang, ZHANG Binbin. Correlation among personality traits and depression, anxiety symptoms in patients after colorectal cancer resection [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 91-96.
[14] Xiaoping XING. Diagnosis and management of primary osteoporosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 1-4.
[15] Guoyun WANG,Kai WANG,Ming YUAN,Zijiang CHEN. Multidimensional management system for endometriosis (The Program for Shandong Province) [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 1-16.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!